Lung Bioengineering

Stories

FDA approves United Therapeutics LungFX to reassess discarded donor lungs

Operator of centralized lung perfusion facilities

More than 8 in 10 donor lungs recovered from deceased donors never reach a patient. On June 29, 2026, the FDA approved a device built to change that math. United Therapeutics won premarket approval for LungFX, a system that keeps donor lungs warm, ventilated, and pumped with fluid outside the body so transplant teams can re-examine organs they had already rejected.

Updated Jun 29